User profiles for Victoria Cardona
Victoria CardonaHospital Vall d'Hebron Verified email at vallhebron.cat Cited by 15227 |
EAACI guidelines: Anaphylaxis (2021 update)
Anaphylaxis is a clinical emergency which all healthcare professionals need to be able to
recognize and manage. The European Academy of Allergy and Clinical Immunology …
recognize and manage. The European Academy of Allergy and Clinical Immunology …
[HTML][HTML] World allergy organization anaphylaxis guidance 2020
Anaphylaxis is the most severe clinical presentation of acute systemic allergic reactions.
The occurrence of anaphylaxis has increased in recent years, and subsequently, there is a …
The occurrence of anaphylaxis has increased in recent years, and subsequently, there is a …
[HTML][HTML] International consensus on (ICON) anaphylaxis
ICON: Anaphylaxis provides a unique perspective on the principal evidence-based anaphylaxis
guidelines developed and published independently from 2010 through 2014 by four …
guidelines developed and published independently from 2010 through 2014 by four …
[HTML][HTML] IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper
…, T Haahtela, M Antila, JJ Bousquet, V Cardona… - World allergy …, 2020 - Elsevier
Currently, testing for immunoglobulin E (IgE) sensitization is the cornerstone of diagnostic
evaluation in suspected allergic conditions. This review provides a thorough and updated …
evaluation in suspected allergic conditions. This review provides a thorough and updated …
Is diet partly responsible for differences in COVID‐19 death rates between and within countries?
…, H Blain, GW Canonica, V Cardona… - Clinical and …, 2020 - Wiley Online Library
Reported COVID‐19 deaths in Germany are relatively low as compared to many European
countries. Among the several explanations proposed, an early and large testing of the …
countries. Among the several explanations proposed, an early and large testing of the …
Usefulness and limitations of sequential serum tryptase for the diagnosis of anaphylaxis in 102 patients
A Sala-Cunill, V Cardona, M Labrador-Horrillo… - International archives of …, 2013 - karger.com
Background: The diagnosis of anaphylaxis is based on clinical history since no reliable
biological marker is currently available to confirm the diagnosis. Objective: It was the aim of this …
biological marker is currently available to confirm the diagnosis. Objective: It was the aim of this …
[HTML][HTML] Research needs in allergy: an EAACI position paper, in collaboration with EFA
In less than half a century, allergy, originally perceived as a rare disease, has become a
major public health threat, today affecting the lives of more than 60 million people in Europe, …
major public health threat, today affecting the lives of more than 60 million people in Europe, …
Factors increasing the risk for a severe reaction in anaphylaxis: An analysis of data from The European Anaphylaxis Registry
Background Preventive measures to decrease the frequency and intensity of anaphylactic
events are essential to provide optimal care for allergic patients. Aggravating factors may …
events are essential to provide optimal care for allergic patients. Aggravating factors may …
[HTML][HTML] COVID-19 vaccine-associated anaphylaxis: a statement of the World Allergy Organization Anaphylaxis Committee
…, IJ Ansotegui, DE Campbell, V Cardona… - World Allergy …, 2021 - Elsevier
Vaccines against COVID-19 (and its emerging variants) are an essential global intervention
to control the current pandemic situation. Vaccines often cause adverse events; however, …
to control the current pandemic situation. Vaccines often cause adverse events; however, …
2019 ARIA Care pathways for allergen immunotherapy
Allergen immunotherapy (AIT) is a proven therapeutic option for the treatment of allergic rhinitis
and/or asthma. Many guidelines or national practice guidelines have been produced but …
and/or asthma. Many guidelines or national practice guidelines have been produced but …